Cargando…
Risk in CNS drug discovery: focus on treatment of Alzheimer's Disease
Despite rapid progress in our understanding of disease mechanisms and an exploding list of new targets for therapeutic intervention, drug discovery and development remains a highly risky business. Understanding the risk involved requires appreciation of the differing perspectives of risk held by the...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604886/ https://www.ncbi.nlm.nih.gov/pubmed/19090998 http://dx.doi.org/10.1186/1471-2202-9-S3-S1 |